secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001651308-25-000148
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

BeOne Medicines secures $1B senior secured financing facilities with HSBC-led syndicate
--------------------------------------------------------------------------------

- Facilities include $140M B1 revolver, $560M B2 term loan (USD), and ~$300M A term loan (RMB), totaling $1B.
- B loan facilities mature 24 months from first draw; A loan matures 36 months. Interest margins: 2.40% (B loans), 0.65% (A loan).
- Proceeds used for general corporate purposes including refinancing existing offshore indebtedness and working capital.
- Covenants include minimum cash interest coverage 5.00x, net leverage ≤2.50x, minimum equity $2.7B, minimum cash $500M outside PRC.
- Security includes pledges on equity interests and mortgage on New Jersey manufacturing/R&D facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000148/0001651308-25-000148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130825000148/bgne-20251113.htm
  HTML page:      https://secwatch.observer/filing/0001651308-25-000148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer